Immuno-Oncology | Specialty

Pharmaceutical Leaders Highlight Promise of TIGIT

February 9th 2017

John Hunter, PhD, and Maya Kotturi, PhD, answer key questions about TIGIT as a target for anticancer therapy and the current development of TIGIT-targeting drugs.

Expert Discusses PD-1 Success in MSI-H Colorectal Cancer

February 9th 2017

Michael J. Overman, MD, discusses the significance of the ongoing CheckMate-142 study and the next steps in microsatellite instability-high metastatic colorectal cancer.

Dr. Ku on Immunotherapy in Gastric and Esophageal Cancer

February 9th 2017

Geoffrey Y. Ku, MD, medical oncologist at Memorial Sloan Kettering Cancer Center discusses immunotherapy treatments for patients with gastric and esophageal cancers.

TIGIT Emerges as New Target for Immune Checkpoint Blockade Strategies

February 9th 2017

As researchers continue to identify a growing number of immune checkpoints as targets for anticancer therapy, the recently discovered TIGIT pathway is emerging as a promising new avenue for exploration.

Dr. Mutti on Current Role of Immunotherapy for Mesothelioma

February 9th 2017

Luciano Mutti, MD, professor of Cancer Research, University of Salford Manchester, discusses the current role of immunotherapy for patients with mesothelioma.

Less Common Side Effects With Immunotherapy in Melanoma

February 8th 2017

Immunotherapy in Melanoma: Recognizing an Endocrinopathy

February 8th 2017

Melanoma: Testing for Immunotherapy-Related Hepatotoxicity

February 8th 2017

Immunotherapy-Related Pulmonary Toxicities in Melanoma

February 8th 2017

Managing Gastrointestinal Toxicities in Melanoma

February 8th 2017

Melanoma: Management of Dermatologic Toxicities

February 8th 2017

Overall Toxicities With Immunotherapy in Melanoma

February 8th 2017

Monotherapy Versus Combination Therapy Approaches in Melanoma

February 8th 2017

Melanoma: Speed and Durability of Therapeutic Response

February 8th 2017

BRAF-Mutant Melanoma: Frontline Decisions

February 8th 2017

Immunotherapy in BRAF Wild-Type Melanoma

February 8th 2017

Initial Treatment Approach in Advanced Melanoma: Factors to Consider

February 8th 2017

Explaining Therapeutic Options to Patients With Advanced Melanoma

February 8th 2017

Multidisciplinary Care for Advanced Melanoma at Georgetown University

February 8th 2017

Team Approach to Advanced Melanoma Treatment at MSKCC

February 8th 2017